{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:53:39Z","timestamp":1778957619231,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.4158\/ep14291.cr","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T21:59:07Z","timestamp":1407880747000},"page":"229-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Falsely Decreased Hba1c in A Type 2 Diabetic Patient Treated with Dapsone"],"prefix":"10.1016","volume":"20","author":[{"given":"Arti D.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena K.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Rushakoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP14291.CR_bb0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3748\/wjg.15.280","article-title":"Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management","volume":"15","author":"Garcia-Compean","year":"2009","journal-title":"World J Gastroenterol."},{"key":"10.4158\/EP14291.CR_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000343458","article-title":"Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus","volume":"87","author":"Gundling","year":"2013","journal-title":"Digestion."},{"key":"10.4158\/EP14291.CR_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1753-0407.2009.00009.x","article-title":"Review of hemoglobin A(1c) in the management of diabetes","volume":"1","author":"Gallagher","year":"2009","journal-title":"J Diabetes."},{"key":"10.4158\/EP14291.CR_bb0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4103\/2230-8210.98004","article-title":"Drugs affecting HbA1c levels","volume":"16","author":"Unnikrishnan","year":"2012","journal-title":"Indian J Endocrinol Metab."},{"key":"10.4158\/EP14291.CR_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jfma.2012.01.007","article-title":"Falsely decreased HbA1c in a type 2 diabetic patient treated with dapsone","volume":"111","author":"Lai","year":"2012","journal-title":"J Formos Med Assoc."},{"key":"10.4158\/EP14291.CR_bb0030","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11606-013-2595-x","article-title":"Pitfalls in hemoglobin A1c measurement: when results may be misleading","volume":"29","author":"Radin","year":"2014","journal-title":"J Gen Intern Med."},{"key":"10.4158\/EP14291.CR_bb0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"10.4158\/EP14291.CR_bb0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/QAD.0b013e32835adde8","article-title":"Dapsone interferes with hemoglobin A1c monitoring of diabetes in an HIV-infected patient","volume":"27","author":"Roxby","year":"2013","journal-title":"AIDS."},{"key":"10.4158\/EP14291.CR_bb0045","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1086\/376633","article-title":"Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus","volume":"37","author":"Polgreen","year":"2003","journal-title":"Clin Infect Dis."},{"key":"10.4158\/EP14291.CR_bb0050","first-page":"508","article-title":"Interference of dapsone in HbA1c monitoring of a diabetic patient with polychondritis","volume":"28","author":"Serratrice","year":"2002","journal-title":"Diabetes Metab."},{"key":"10.4158\/EP14291.CR_bb0055","first-page":"505","article-title":"Dapsoneinduced decrease in the HbA(1c) level may cause artefacts in diabetic control [in Danish]","volume":"175","author":"Lajlev","year":"2013","journal-title":"Ugeskr Laeger."},{"key":"10.4158\/EP14291.CR_bb0060","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4103\/2230-8210.98037","article-title":"Unexpectedly low HbA1c levels in two diabetes patients following dapsone use","volume":"16","author":"Unnikrishnan","year":"2012","journal-title":"Indian J Endocrinol Metab."},{"key":"10.4158\/EP14291.CR_bb0065","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4158\/EP.8.5.370","article-title":"Artificially low hemoglobin A1c caused by use of dapsone","volume":"8","author":"Albright","year":"2002","journal-title":"Endocr Pract."},{"key":"10.4158\/EP14291.CR_bb0070","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMcpc1013923","article-title":"Case records of the Massachusetts General Hospital: Case 7-2011: a 52-yearold man with upper respiratory symptoms and low oxygen saturation levels","volume":"364","author":"Pallais","year":"2011","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14291.CR_bb0075","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.tp.0000257918.71325.07","article-title":"Dapsone-induced artifactual A1c reduction in islet transplant recipients","volume":"83","author":"Froud","year":"2007","journal-title":"Transplantation."},{"key":"10.4158\/EP14291.CR_bb0080","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/diacare.17.11.1364a","article-title":"Interference of dapsone in HbA1c monitoring of a type I diabetic patient with necrobiosis lipoidica","volume":"17","author":"Bertholon","year":"1994","journal-title":"Diabetes Care."},{"key":"10.4158\/EP14291.CR_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2337\/diacare.19.7.775","article-title":"Decreased HbA1c levels due to sulfonamide-induced hemolysis in two IDDM patients","volume":"19","author":"Tack","year":"1996","journal-title":"Diabetes Care."},{"key":"10.4158\/EP14291.CR_bb0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4103\/2230-8210.98036","article-title":"Artifactually lowered glycosylated hemoglobin (HbA1c %) in patient with diabetes on dapsone","volume":"16","author":"Rastogi","year":"2012","journal-title":"Indian J Endocrinol Metab."},{"key":"10.4158\/EP14291.CR_bb0095","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/CMR.17.4.770-782.2004","article-title":"Prevention of infection due to Pneumocystis spp. in human immunodeficiency virusnegative immunocompromised patients","volume":"17","author":"Rodriguez","year":"2004","journal-title":"Clin Microbiol Rev."},{"key":"10.4158\/EP14291.CR_bb0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3727\/096368909788809848","article-title":"Clinical use of fructosamine in islet transplantation","volume":"18","author":"Tharavanij","year":"2009","journal-title":"Cell Transplant."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/B5114H64N7102RU5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:57:48Z","timestamp":1761515868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20419330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1530891X20419330"],"URL":"https:\/\/doi.org\/10.4158\/ep14291.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Falsely Decreased Hba1c in A Type 2 Diabetic Patient Treated with Dapsone","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14291.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}